Professional Background

Dr. Singh has held senior leadership roles at Max Healthcare, Maulana Azad Medical College, and Eternal University. He served as Medical Director at Max Super Speciality Hospital, Vaishali, and as Senior Director and Senior Consultant in Internal Medicine and Nephrology at Max Healthcare for nearly a decade. He is currently Professor-cum-Dean (Research) at Eternal University, Himachal Pradesh, and Consultant for Academic Programs (Nephrology) at Max Super Speciality Hospital, Saket. Throughout his career, he has chaired Institutional Ethics Committees, overseen safety monitoring and SAE review, and led clinical drug trials across chronic kidney disease, renal anemia, and cardiovascular therapeutics. Dr. Singh is a collaborator with the Institute for Health Metrics and Evaluation (IHME), University of Washington, on the Global Burden of Disease program and has been a National Coordinator for NBE–DNB General Medicine, MRCP(UK) PACES Examiner, and Principal Investigator on multiple ICMR, UGC, and DST research projects. With over 210 publications, 41 book chapters, 8 edited books, and supervision of more than 100 postgraduate theses, he brings deep academic and clinical expertise to safety governance and benefit–risk evaluation.

Core Expertise

• Pharmacovigilance, patient safety, and clinical trial safety oversight
• Benefit–risk assessment in vulnerable populations (CKD, elderly, multimorbidity)
• Post-marketing surveillance and real-world evidence generation
• Safety signal detection, risk communication, and mitigation strategies
• Ethics committees, regulatory compliance, and protocol review

Career Highlights

• Chaired and served on Institutional Ethics Committees at multiple tertiary hospitals, overseeing safety monitoring, SAE review, and risk mitigation.
• Conducted and supervised safety oversight for more than 12 clinical drug trials in chronic kidney disease and served as National Lead Investigator in global multicentric trials on renal anemia.
• Extensive experience in post-marketing safety surveillance and real-world outcome assessments in routine clinical practice.
• Expert in benefit–risk evaluation of therapies for vulnerable populations and actively involved in safety governance and regulatory compliance aligned with national and international standards.
• Collaborator with IHME, University of Washington, on the Global Burden of Disease program and referee/expert evaluator for ICMR extramural research proposals.

Awards & Recognition (Selected)

• State Award for Meritorious Service, Government of NCT of Delhi
• Lifetime Achievement Awards — ANBAI & Institution for Environmental Yoga & Social Security
• Max CEO's Award & Healing Hands Award
• H-index: 38 (Google Scholar) | Publications: 160 indexed, 51 non-indexed

Education & Clinical Training

• MBA (Healthcare Administration) — Delhi University
• MD (Internal Medicine) — Delhi University
• MBBS — Delhi University

Therapeutic Focus